Anti-CD79b Anticorps (A318804)

Polatuzumab Biosimilar - Anti-CD79b Antibody - BSA and Azide free

Recombinant humanized monoclonal antibody to CD79b.

ELISA, Flow Cytometry

ELISA: 1:5,000-10,000, Flow Cytometry: 1:100

Human

Humanized

Monoclonal

IgG1

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

AGM6, B cell antigen receptor complex associated protein beta chain, B cell specific glycoprotein B29, B-cell antigen receptor complex-associated protein beta chain, B-cell-specific glycoprotein B29, B29, B29/Ig-beta/CD79b, CD 79b, CD79b antigen, CD79b antigen (immunoglobulin associated beta), CD79b molecule, CD79b molecule immunoglobulin associated beta, CD79b protein, CD79B_HUMAN, Ig beta, Ig-beta, IGB, Igbeta, Immunoglobulin associated B29, Immunoglobulin associated B29 protein, Immunoglobulin associated beta, Immunoglobulin associated protein, Immunoglobulin-associated B29 protein, MGC108607